Redmile Group, LLC

Shattuck Labs, Inc. · Director, 10% Owner

Redmile Group, LLC is listed in filings as Director, 10% Owner at Shattuck Labs, Inc.. This profile follows SEC Form 4 activity through Apr 23, 2026, including sale activity and purchase activity. Recent filings connect the profile to Shattuck Labs, Inc. (STTK), IGM Biosciences, Inc. (IGMS), FATE THERAPEUTICS INC (FATE), and Augmedix, Inc. (AUGX). The current snapshot covers public activity from Jun 14, 2024 to Apr 23, 2026. Reported amounts are shown as $121.0K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Shattuck Labs, Inc.STTK$167k133.4k sharesSellDec 4, 2024$1.25$7.45
Shattuck Labs, Inc.STTK$167k133.4k sharesBuyDec 4, 2024$1.25$7.45
FATE THERAPEUTICS INCFATE$574k341.6k sharesSellDec 20, 2024$1.68$2.73
FATE THERAPEUTICS INCFATE$669k398k sharesBuyDec 20, 2024$1.68$2.73
ADC Therapeutics S.A.ADCT$1M400k sharesBuyJul 1, 2024$2.81$1.35
ADC Therapeutics S.A.ADCT$52k25.4k sharesSellDec 4, 2024$2.07$1.35
ADC Therapeutics S.A.ADCT$114k50k sharesBuyDec 11, 2024$2.28$1.35
ADC Therapeutics S.A.ADCT$191k50k sharesBuyDec 11, 2024$3.81$1.35
ADC Therapeutics S.A.ADCTDisclosure amount unavailable12.5M sharesBuyJun 11, 2025--$1.35
ADC Therapeutics S.A.ADCTDisclosure amount unavailable15.7M sharesBuyJun 11, 2025--$1.35
ADC Therapeutics S.A.ADCTDisclosure amount unavailable3.8M sharesBuyOct 27, 2025--$1.35
ADC Therapeutics S.A.ADCT$617k162.5k sharesSellApr 1, 2026$3.80$1.35
ADC Therapeutics S.A.ADCT$707k188.4k sharesSellMar 31, 2026$3.75$1.35
ADC Therapeutics S.A.ADCT$643k169.3k sharesSellApr 1, 2026$3.80$1.35
ADC Therapeutics S.A.ADCT$736k196.2k sharesSellMar 31, 2026$3.75$1.35